|
Powered by Cell Signaling Technology |
Peptide | References | |
---|---|---|
VKLTAELIEQAAQYTNAVR | 1, 2, 3 | 42757 View spectrum 42765 View spectrum 42962 View spectrum 45324 View spectrum 45335 View spectrum 45965 View spectrum 45986 View spectrum |
References | |
---|---|
Rikova K (2012) CST Curation Set: 16030; Year: 2012; Biosample/Treatment: cell line, MKN45/crizotinib; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK | |
Rikova K (2012) CST Curation Set: 16031; Year: 2012; Biosample/Treatment: cell line, H3255/iressa; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK | |
Rikova K (2012) CST Curation Set: 16032; Year: 2012; Biosample/Treatment: cell line, H1703/gleevec; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK |